| Title: |
Can cardiovascular disease guidelines that advise treatment decisions based on absolute risk be improved? |
| Authors: |
Campbell, DJ |
| Issue Year: |
2016 |
| Publisher |
BIOMED CENTRAL LTD |
| Series |
BMC Cardiovasc. Disord.: |
| Abstract |
Background: Cardiovascular disease (CVD) will remain the predominant cause of death and a major cause of morbidity for the foreseeable future. Consequently, CVD prevention offers the greatest potential for the prevention of premature mortality and the compression of morbidity. Discussion: The 2013 guidelines of the American College of Cardiology and the American Heart Association expand the eligibility for CVD preventive treatment based on the calculated 10-year CVD risk derived from the pooled cohort equation to all persons who have a 10-year risk of CVD of >= 7.5% as estimated by the pooled cohort equation. Previous analyses show that the use of a uniform 10-year risk threshold of 7.5% for all ages disadvantages younger individuals for whom preventive therapy has most to offer. Here I show that reducing the threshold to 3% in younger adults (women aged < 66 years and men aged < 56 years) will substantially increase the number of cardiovascular events prevented at a similar number needed to treat to prevent one event. Importantly, this increase in cardiovascular event prevention will occur in individuals with greater life expectancy. Conclusion: Reducing the threshold 10-year risk of CVD derived from the pooled cohort equation for CVD preventive treatment to 3% in younger adults (women aged < 66 years and men aged < 56 years) will more effectively prevent premature mortality and compress morbidity to an older age. |
| URI: |
https://publications.svi.edu.au/publications/6408 |
| Other Identifiers |
10.1186/s12872-016-0396-y |
| Publication type |
Article |